Amendment: SEC Form SC 13D/A filed by Invesco California Value Municipal Income Trust
INVESCO CALIFORNIA VALUE MUNICIPAL INCOME TRUST
|
(Name of Issuer)
|
Series 2015/6-VCV Variable Rate Muni Term Preferred Shares
|
(Title of Class of Securities)
|
46132H601
|
(CUSIP Number)
|
Bank of America Corporation
Bank of America Corporate Center
100 N. Tryon Street
Charlotte, North Carolina 28255
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
June 10, 2020
|
(Date of Event which Requires Filing of this Statement)
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Bank of America Corporation
56-0906609
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☒
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
||||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☒
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
1,770
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
1,770
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
1,770
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
100%*
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
HC
|
|
|
|||
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Banc of America Preferred Funding Corporation
75-2939570
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☒
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
1,770
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
1,770
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
1,770
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
100%*
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
CO
|
|
|
|||
|
|
Item 2. |
Identity and Background
|
Item 5. |
Interest in Securities of the Issuer
|
Item 7. |
Material to be Filed as Exhibits
|
Exhibit No.
|
Description
|
|
Joint Filing Agreement, dated as of December 13, 2024, by and among the Reporting Persons.
|
Date: December 13, 2024. | ||
BANK OF AMERICA CORPORATION
|
||
By:
|
/s/ Andres Ortiz
|
|
Name: Andres Ortiz
|
||
Title: Authorized Signatory
|
||
BANC OF AMERICA PREFERRED FUNDING CORPORATION
|
||
By:
|
/s/ Andres Ortiz
|
|
Name: Andres Ortiz
|
||
Title: Authorized Signatory
|
Name
|
Position with Bank of
America Corporation
|
Principal Occupation
|
||
Brian T. Moynihan
|
Chairman of the Board, Chief Executive Officer and Director
|
Chairman of the Board and Chief Executive Officer of Bank of America Corporation
|
||
Paul M. Donofrio
|
Vice Chair
|
Vice Chair of Bank of America Corporation
|
||
Thong M. Nguyen
|
Vice Chair, Head of Global Strategy & Enterprise Platforms
|
Vice Chair, Head of Global Strategy & Enterprise Platforms of Bank of America Corporation
|
||
Bruce R. Thompson
|
Vice Chair, Head of Enterprise Credit
|
Vice Chair, Head of Enterprise Credit of Bank of America Corporation
|
||
Dean C. Athanasia
|
President, Regional Banking
|
President, Regional Banking of Bank of America Corporation
|
||
James P. DeMare
|
President, Global Markets
|
President, Global Markets of Bank of America Corporation
|
||
Kathleen A. Knox
|
President, The Private Bank
|
President, The Private Bank of Bank of America Corporation
|
||
Matthew M. Koder
|
President, Global Corporate and Investment Banking
|
President, Global Corporate and Investment Banking of Bank of America Corporation
|
||
Bernard A. Mensah
|
President, International; CEO, Merrill Lynch International
|
President, International of Bank of America Corporation and CEO, Merrill Lynch International
|
||
Lindsay DeNardo Hans
|
President, Co-Head Merrill Wealth Management
|
President, Co-Head Merrill Wealth Management of Bank of America Corporation
|
||
Eric Schimpf
|
President, Co-Head Merrill Wealth Management
|
President, Co-Head Merrill Wealth Management of Bank of America Corporation
|
||
Aditya Bhasin
|
Chief Technology and Information Officer
|
Chief Technology and Information Officer of Bank of America Corporation
|
||
D. Steve Boland
|
Chief Administrative Officer
|
Chief Administrative Officer of Bank of America Corporation
|
||
Alastair Borthwick
|
Chief Financial Officer
|
Chief Financial Officer of Bank of America Corporation
|
||
Sheri Bronstein | Chief Human Resources Officer | Chief Human Resources Officer of Bank of America Corporation | ||
Geoffrey Greener | Chief Risk Officer | Chief Risk Officer of Bank of America Corporation | ||
Thomas M. Scrivener | Chief Operations Executive | Chief Operations Executive of Bank of America Corporation | ||
Lauren A. Mogensen | Global General Counsel | Global General Counsel of Bank of America Corporation | ||
Lionel L. Nowell, III | Lead Independent Director | Lead Independent Director, Bank of America Corporation; Former Senior Vice President and Treasurer, PepsiCo, Inc. | ||
Sharon L. Allen | Director | Former Chairman, Deloitte LLP | ||
Jose E. Almeida | Director | Chairman, President and Chief Executive Officer of Baxter International Inc. | ||
Pierre J.P. de Weck1 | Director | Former Chairman and Global Head of Private Wealth Management, Deutsche Bank AG | ||
Arnold W. Donald | Director | Former President and Chief Executive Officer, Carnival Corporation & Carnival plc | ||
Linda P. Hudson | Director | Former Executive Officer, The Cardea Group, LLC and Former President and Chief Executive Officer of BAE Systems, Inc. | ||
Monica C. Lozano | Director | Lead Independent Director, Target Corporation; Former Chief Executive Officer, Former College Futures Foundation and Former Chairman, US Hispanic Media Inc. | ||
Denise L. Ramos | Director | Former Chief Executive Officer and President of ITT Inc. | ||
Clayton S. Rose | Director | Baker Foundation Professor of Management Practice at Harvard Business School | ||
Michael D. White | Director | Former Chairman, President, and Chief Executive Officer of DIRECTV | ||
Thomas D. Woods2 | Director | Former Vice Chairman and Senior Executive Vice President of Canadian Imperial Bank of Commerce; Former Chairman, Hydro One Limited | ||
Maria T. Zuber | Director | Vice President for Research and E.A., Griswold Professor of Geophysics, MIT |
Name
|
Position with Banc of
America Preferred Funding
Corporation
|
Principal Occupation
|
||
John J. Lawlor
|
Director and President
|
Managing Director, Municipal Markets and Public Sector Banking Executive of BofA Securities, Inc. and Bank of America, National Association
|
||
James Duffy
|
Managing Director
|
Director; MBAM BFO, The CFO Group
of Bank of America, National Association
|
||
Michael I. Jentis
|
Managing Director
|
Managing Director, Head of Sales – Public Finance of BofA Securities, Inc. and Bank of America, National Association
|
||
Mona Payton
|
Managing Director
|
Managing Director, Municipal Markets Executive for Short-Term Trading of BofA Securities, Inc. and Bank of America, National Association
|
||
Edward J. Sisk
|
Director and Managing Director
|
Managing Director, Public Finance Executive of BofA Securities, Inc. and Bank of America, National Association
|
||
John B. Sprung
|
Director
|
Corporate Director
|
||
David A. Stephens
|
Director and Managing Director
|
Managing Director, Executive for Public Finance and Public Sector Credit Products of BofA Securities, Inc. and Bank of America, National Association
|
TRADE DATE
|
BUY/SELL
|
QUANTITY
|
PRICE
|
EXECUTION
|
|||||||
06/10/2020
|
B
|
216
|
$
|
11.65
|
NYSE
|
||||||
06/10/2020
|
B
|
251
|
$
|
11.65
|
NYSE
|
||||||
06/10/2020
|
B
|
200
|
$
|
11.65
|
NYSE
|
||||||
06/10/2020
|
B
|
48
|
$
|
11.65
|
NYSE
|
||||||
06/10/2020
|
B
|
200
|
$
|
11.65
|
NYSE
|
||||||
06/10/2020
|
B
|
261
|
$
|
11.65
|
NYSE
|
||||||
06/10/2020
|
B
|
100
|
$
|
11.65
|
NYSE
|
||||||
06/10/2020
|
S
|
216
|
$
|
11.65
|
OTC
|
||||||
06/10/2020
|
S
|
261
|
$
|
11.65
|
OTC
|
||||||
06/10/2020
|
S
|
200
|
$
|
11.65
|
OTC
|
||||||
06/10/2020
|
S
|
251
|
$
|
11.65
|
OTC
|
||||||
06/10/2020
|
S
|
100
|
$
|
11.65
|
OTC
|
||||||
06/10/2020
|
S
|
48
|
$
|
11.65
|
OTC
|
||||||
06/10/2020
|
S
|
200
|
$
|
11.65
|
OTC
|
||||||
08/14/2020
|
B
|
6,000
|
$
|
12.6661
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.07
|
OTC
|
||||||
08/27/2020
|
S
|
99
|
$
|
12.07
|
OTC
|
||||||
08/27/2020
|
S
|
99
|
$
|
12.07
|
OTC
|
||||||
08/27/2020
|
S
|
35
|
$
|
12.07
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.07
|
OTC
|
||||||
08/27/2020
|
S
|
99
|
$
|
12.07
|
OTC
|
||||||
08/27/2020
|
S
|
99
|
$
|
12.07
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.06
|
OTC
|
||||||
08/27/2020
|
S
|
300
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
1,000
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
405
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
200
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
99
|
$
|
12.06
|
OTC
|
||||||
08/27/2020
|
S
|
200
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
200
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
96
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
200
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
200
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
200
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.06
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.05
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.06
|
OTC
|
||||||
08/27/2020
|
S
|
20
|
$
|
12.06
|
OTC
|
||||||
08/27/2020
|
S
|
80
|
$
|
12.06
|
OTC
|
||||||
08/27/2020
|
S
|
300
|
$
|
12.03
|
OTC
|
||||||
08/27/2020
|
S
|
16
|
$
|
12.04
|
OTC
|
||||||
08/27/2020
|
S
|
284
|
$
|
12.03
|
OTC
|
||||||
08/27/2020
|
S
|
200
|
$
|
12.03
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.03
|
OTC
|
||||||
08/27/2020
|
S
|
300
|
$
|
12.03
|
OTC
|
||||||
08/27/2020
|
S
|
300
|
$
|
12.03
|
OTC
|
||||||
08/27/2020
|
S
|
100
|
$
|
12.03
|
OTC
|
||||||
08/27/2020
|
S
|
69
|
$
|
12.03
|
OTC
|
||||||
09/03/2020
|
S
|
2,300
|
$
|
12.58
|
OTC
|
||||||
09/03/2020
|
S
|
7,000
|
$
|
12.58
|
OTC
|
||||||
09/08/2020
|
B
|
2,300
|
$
|
12.4
|
OTC
|
||||||
09/08/2020
|
B
|
431
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
400
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
300
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
200
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
277
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
23
|
$
|
12.43
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
600
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
567
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
200
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
400
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
300
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
600
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.44
|
OTC
|
||||||
09/08/2020
|
B
|
300
|
$
|
12.45
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.45
|
OTC
|
||||||
09/08/2020
|
B
|
200
|
$
|
12.45
|
OTC
|
||||||
09/08/2020
|
B
|
2
|
$
|
12.46
|
OTC
|
||||||
09/08/2020
|
B
|
100
|
$
|
12.46
|
OTC
|
||||||
09/08/2020
|
B
|
200
|
$
|
12.46
|
OTC
|
||||||
09/08/2020
|
B
|
200
|
$
|
12.46
|
OTC
|
||||||
09/17/2020
|
S
|
50
|
$
|
12.4332
|
OTC
|
||||||
09/21/2020
|
B
|
50
|
$
|
12.48
|
OTC
|
||||||
04/16/2021
|
S
|
208
|
$
|
13.185
|
OTC
|
||||||
04/19/2021
|
B
|
208
|
$
|
13.1954
|
OTC
|
||||||
06/11/2021
|
S
|
50
|
$
|
13.8408
|
OTC
|
||||||
06/14/2021
|
B
|
50
|
$
|
13.75
|
OTC
|
||||||
11/17/2022
|
S
|
2,000
|
$
|
9.2
|
OTC
|
||||||
12/05/2022
|
B
|
100
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
291
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
69
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
219
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
167
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
100
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
132
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
54
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
100
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
59
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
B
|
200
|
$
|
10.04
|
NYSE
|
||||||
12/05/2022
|
S
|
69
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
167
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
291
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
200
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
100
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
219
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
100
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
59
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
54
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
132
|
$
|
10.04
|
OTC
|
||||||
12/05/2022
|
S
|
100
|
$
|
10.04
|
OTC
|
||||||
12/27/2022
|
B
|
1,813
|
$
|
9.38
|
OTC
|
||||||
12/27/2022
|
B
|
187
|
$
|
9.38
|
OTC
|
||||||
06/05/2023
|
B
|
499
|
$
|
9.38
|
OTC
|
||||||
06/05/2023
|
S
|
100
|
$
|
9.4
|
AMEX
|
||||||
06/05/2023
|
S
|
100
|
$
|
9.4
|
OTC
|
||||||
06/05/2023
|
S
|
43
|
$
|
9.4
|
AMEX
|
||||||
06/05/2023
|
S
|
6
|
$
|
9.4
|
AMEX
|
||||||
06/05/2023
|
S
|
100
|
$
|
9.42
|
OTC
|
||||||
06/05/2023
|
S
|
25
|
$
|
9.42
|
AMEX
|
||||||
06/05/2023
|
S
|
31
|
$
|
9.42
|
AMEX
|
||||||
06/05/2023
|
S
|
51
|
$
|
9.42
|
OTC
|
||||||
06/05/2023
|
S
|
43
|
$
|
9.44
|
NYSE
|
||||||
06/05/2023
|
B
|
1,583
|
$
|
9.39
|
NYSE
|
||||||
06/05/2023
|
S
|
1,583
|
$
|
9.39
|
OTC
|
||||||
06/12/2023
|
B
|
469
|
$
|
9.51
|
OTC
|
||||||
06/13/2023
|
S
|
469
|
$
|
9.555
|
OTC
|
||||||
12/13/2023
|
B
|
900
|
$
|
9.58
|
OTC
|
||||||
12/15/2023
|
S
|
100
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
100
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
154
|
$
|
9.725
|
AMEX
|
||||||
12/15/2023
|
S
|
46
|
$
|
9.72
|
NYSE
|
||||||
12/15/2023
|
S
|
100
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
100
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
100
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
21
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
100
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
21
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
21
|
$
|
9.725
|
OTC
|
||||||
12/15/2023
|
S
|
21
|
$
|
9.725
|
AMEX
|
||||||
12/15/2023
|
S
|
16
|
$
|
9.725
|
AMEX
|
||||||
09/19/2024
|
S
|
3,477
|
$
|
10.963
|
OTC
|
||||||
09/19/2024
|
B
|
137
|
$
|
11.0
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
11.0
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
400
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
11.0
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
11.0
|
OTC
|
||||||
09/19/2024
|
B
|
400
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
300
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
500
|
$
|
11.0
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
200
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
400
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
100
|
$
|
10.99
|
OTC
|
||||||
09/19/2024
|
B
|
40
|
$
|
10.99
|
OTC
|
TRADE DATE
|
BUY/SELL
|
QUANTITY
|
PRICE
|
EXECUTION
|
04/12/2022
|
B
|
1,000
|
100%
|
OTC
|